These trials included individuals living with obesity, with or without T2D
Modelling and simulation of semaglutide at different doses has suggested that a dose higher than the currently approved 24 mg might provide further bodyweight reduction and health benefits without jeopardising safety. What an odd thing to say
The STEP 4 trial showed that patients who stopped semaglutide after 68 weeks of treatment regained, on average, two-thirds of their lost weight within 52 weeks of discontinuation (Rubino et al., NEJM, 2021)
Absolutely stellar experience with this company
This section is a summary of the feedback received from the patient groups, registered clinicians, and drug plans that participated in the CADTH review process
This controlled heating process activates the bodys natural healing response, encouraging collagen remodeling and gradually lifting and tightening loose skin